Search Results

Sending information via email.docx

HRP20 Supporting and Maintaining Attendance Policy

v2 November 2025

FINAL Chief Executive Designate - Stakeholder Briefing - 11 November 2021.pdf

Dr Chris Clayton appointment; Chief Executive JUCD

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Employee online user guide - temporary staffing.pdf

Disclosure Ref 202243 - Agency for Biomedical SciencePathology - Copy.pdf

WRES data report 2023.docx

APPENDIX 4 Application for Adoption Leave and Pay Form.docx

Organisational strategy - Bitesize slides - Healthy Communities.pptx

Organisational strategy - Bitesize slides - Healthy Communities.pptx

Trust Policy for Free of Charge (FOC) Medicines Schemes (P109)

This policy is to ensure consistent, equitable and robust consideration of any free of charge (FOC) scheme that DCHS clinicians would like to be considered for use within DCHS, in line with the National guidance on FOC schemes. Including the requirement for consideration of schemes within Derbyshire for system approval prior to use within DCHS by the Derbyshire Joint Area Prescribing Committee. Where the medicine is currently commissioned by NHS England Specialised Commissioning, ICSs should discuss all FOC schemes with their regional specialised commissioning team in the first instance, before a decision is made on whether to implement the FOC scheme.